Recoding Life

Rewriting the genetic code can lead to a better understanding of how living cells work, and spawn new biotechnological applications.

Written byLaasya Samhita
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

WIKIMEDIA, JFANTASYThese days, it often seems like science is catching up with fiction. Three years ago an entire genome was transplanted from one bacterium to another. Later, the same technique was used to kick-start an enucleated cell by supplying it with a manmade genome, showing that life can be artificially assembled in the lab. Now, researchers are aiming to rewrite the genetic code altogether, changing the amino acids specified by various DNA triplet codes, a relationship thought to have been fixed by years of evolution.

“To make proteins with more than 20 amino acids—possibly as many as 30 or 40—requires thinking outside of the box of the standard genetic code,” said molecular biologist Patrick O’Donoghue from Western University, Ontario, in an e-mail to The Scientist. “We now know there are ways to skew the competition between molecules in the cell so that many codons can take on entirely new meanings. This means there is potentially no limit to the number of amino acids the cell could encode.”

There are several advantages to rewriting the genetic code. Proteins are often modified in ways that are critical to their functions, and the process of introducing these modifications in medically or commercially relevant human proteins made in bacteria can be tedious and inefficient. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies